Sandoz Accuses Eli Lilly Of Inequitable Conduct
By Amanda Ernst · October 12, 2007, 12:00 AM EDT
Generic pharmaceutical company Sandoz Inc. is fighting back against Eli Lilly & Co. in an infringement battle over a patent for attention-deficit hyperactivity disorder treatment Strattera, denying the drug maker's claims...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login